PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30084995 ↗2019Reported benefit

Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.

MouseIschaemia-reperfusionCardiacC57BL/6 including knockout strains; miniature swineMaleIntravenousAt the time of reperfusion in the ischaemia-reperfusion model; starting 6 h aft…

Model: Myocardial ischaemia-reperfusion injury and permanent left anterior descending artery ligation myocardial infarction

Pioglitazone nanoparticles attenuated ischaemia-reperfusion injury, reduced inflammatory monocyte recruitment, promoted M2 macrophage polarisation, attenuated cardiac remodelling and decreased mortality after myocardial infarction, with cardioprotection confirmed in a conscious porcine model. Free…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.72. Machine-extracted fields require source verification.